☰

Krishna Pada Bhabak - Publications

Affiliations: 
2013-2015 Presidency University, Kolkata 
 2015- IIT Guwahati 
Area:
Bioorganic chemistry
Website:
http://www.iitg.ernet.in/kbhabak/Research.html
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sufian A, Badirujjaman M, Barman P, Bhabak KP. Dual-Stimuli-Activatable Hybrid Prodrug for the Self-Immolative Delivery of an Anticancer Agent and Hydrogen Sulfide with Turn-On Fluorescence. Chemistry (Weinheim An Der Bergstrasse, Germany). e202302197. PMID 37665099 DOI: 10.1002/chem.202302197  0.767
2023 Mahato SK, Barman P, Badirujjaman M, Bhabak KP. Cysteine-responsive prodrug of the anti-cancer drug amonafide: fluorogenic adjuvant drug delivery with hydrogen sulfide (HS). Chemical Communications (Cambridge, England). 59: 4802-4805. PMID 37000594 DOI: 10.1039/d3cc00220a  0.756
2022 Bhattacherjee D, Raina K, Mandal TK, Thummer RP, Bhabak KP. Targeting Wnt/β-catenin signaling pathway in triple-negative breast cancer by benzylic organotrisulfides: Contribution of the released hydrogen sulfide towards potent anti-cancer activity. Free Radical Biology & Medicine. 191: 82-96. PMID 36038037 DOI: 10.1016/j.freeradbiomed.2022.08.029  0.359
2022 Sufian A, Bhattacherjee D, Barman P, Srivastava A, Thummer RP, Bhabak KP. Stimuli-responsive prodrug of non-steroidal anti-inflammatory drug diclofenac: self-immolative drug release with turn-on near-infrared fluorescence. Chemical Communications (Cambridge, England). PMID 35748501 DOI: 10.1039/d2cc02132c  0.763
2022 Mahato SK, Bhattacherjee D, Barman P, Bhabak KP. Thioredoxin reductase-triggered fluorogenic donor of hydrogen sulfide: a model study with a symmetrical organopolysulfide probe with turn-on near-infrared fluorescent emission. Journal of Materials Chemistry. B. 10: 2183-2193. PMID 35266940 DOI: 10.1039/d1tb02425f  0.774
2021 Ghosh S, Bhattacherjee D, Satpati P, Bhabak KP. Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease. Journal of Biomolecular Structure & Dynamics. 1-12. PMID 34424151 DOI: 10.1080/07391102.2021.1967786  0.339
2021 Banerjee K, Bhattacherjee D, Mahato SK, Sufian A, Bhabak KP. Benzimidazole- and Imidazole-Fused Selenazolium and Selenazinium Selenocyanates: Ionic Organoselenium Compounds with Efficient Peroxide Scavenging Activities. Inorganic Chemistry. PMID 34369772 DOI: 10.1021/acs.inorgchem.1c01410  0.728
2020 Mahato SK, Bhattacherjee D, Bhabak KP. The biothiol-triggered organotrisulfide-based self-immolative fluorogenic donors of hydrogen sulfide enable lysosomal trafficking. Chemical Communications (Cambridge, England). PMID 32555887 DOI: 10.1039/D0Cc00613K  0.747
2019 Malviya N, Sonkar C, Ganguly R, Bhattacherjee D, Bhabak KP, Mukhopadhyay S. Novel Approach to Generate Self-Deliverable Anticancer Ru(II) agent in the Self-Reacting Confined Gel Space. Acs Applied Materials & Interfaces. PMID 31755256 DOI: 10.1021/Acsami.9B17075  0.413
2019 Bhattacherjee D, Sufian A, Mahato SK, Begum S, Banerjee K, De S, Srivastava HK, Bhabak KP. Trisulfides over disulfides: highly selective synthetic strategies, anti-proliferative activities and sustained HS release profiles. Chemical Communications (Cambridge, England). PMID 31647070 DOI: 10.1039/C9Cc05562B  0.729
2018 Banerjee K, Padmavathi G, Bhattacherjee D, Saha S, Kunnumakkara AB, Bhabak KP. Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer. Organic & Biomolecular Chemistry. PMID 30403243 DOI: 10.1039/C8Ob01891J  0.784
2017 Mandal P, Kundu BK, Vyas K, Sabu V, Helen A, Dhankhar SS, Nagaraja CM, Bhattacherjee D, Bhabak KP, Mukhopadhyay S. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. Dalton Transactions (Cambridge, England : 2003). PMID 29235601 DOI: 10.1039/C7Dt03637J  0.471
2017 Saha M, Vyas KM, Martins LMDRS, Martins NMR, Pombeiro AJL, Mobin SM, Bhattacherjee D, Bhabak KP, Mukhopadhyay S. Copper(II) tetrazolato complexes: Role in oxidation catalysis and protein binding Polyhedron. 132: 53-63. DOI: 10.1016/J.Poly.2017.04.016  0.384
2017 Bhattacherjee D, Basu C, Bhardwaj Q, Mal S, Sahu S, Sur R, Bhabak KP. Design, Synthesis and Anti-Cancer Activities of Benzyl Analogues of Garlic-Derived Diallyl Disulfide (DADS) and the Corresponding Diselenides Chemistryselect. 2: 7399-7406. DOI: 10.1002/SLCT.201700499  0.378
2016 Bhabak KP, Bhowmick D. Synthetic strategies of gold(I)-selenolates from ortho-substituted diaryl diselenides via selenol and selenenyl sulfide intermediates Inorganica Chimica Acta. 450: 337-345. DOI: 10.1016/J.Ica.2016.06.022  0.699
2015 Bhattacherjee D, Bhabak KP. Atom based 3D-QSAR studies on 2,4-dioxopyrimidine-1-carboxamide analogs: Validation of experimental inhibitory potencies towards acid ceramidase. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 83: 8-18. PMID 26658266 DOI: 10.1016/J.Ejps.2015.12.005  0.475
2013 Bhabak KP, Hauser A, Redmer S, Banhart S, Heuer D, Arenz C. Development of a novel FRET probe for the real-time determination of ceramidase activity. Chembiochem : a European Journal of Chemical Biology. 14: 1049-52. PMID 23728798 DOI: 10.1002/Cbic.201300207  0.642
2013 Bhabak KP, Arenz C. Novel drugs targeting sphingolipid metabolism. Handbook of Experimental Pharmacology. 187-96. PMID 23579456 DOI: 10.1007/978-3-7091-1368-4_10  0.622
2013 Bhabak KP, Kleuser B, Huwiler A, Arenz C. Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues. Bioorganic & Medicinal Chemistry. 21: 874-82. PMID 23312611 DOI: 10.1016/J.Bmc.2012.12.014  0.662
2013 Bhabak KP, Hauser A, Redmer S, Banhart S, Heuer D, Arenz C. Cover Picture: Development of a Novel FRET Probe for the Real-Time Determination of Ceramidase Activity (ChemBioChem 9/2013) Chembiochem. 14: 1017-1017. DOI: 10.1002/Cbic.201390029  0.622
2012 Bhabak KP, Arenz C. Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases. Bioorganic & Medicinal Chemistry. 20: 6162-70. PMID 22989912 DOI: 10.1016/J.Bmc.2012.08.031  0.682
2012 Bhabak KP, Proksch D, Redmer S, Arenz C. Novel fluorescent ceramide derivatives for probing ceramidase substrate specificity. Bioorganic & Medicinal Chemistry. 20: 6154-61. PMID 22989909 DOI: 10.1016/J.Bmc.2012.08.035  0.65
2012 Bhabak KP, Bhowmick D. Synthesis and structural characterization of some trisulfide analoges of thiouracil-based antithyroid drugs Journal of Molecular Structure. 1022: 16-24. DOI: 10.1016/J.Molstruc.2012.05.005  0.695
2011 Bhabak KP, Satheeshkumar K, Jayavelu S, Mugesh G. Inhibition of peroxynitrite- and peroxidase-mediated protein tyrosine nitration by imidazole-based thiourea and selenourea derivatives. Organic & Biomolecular Chemistry. 9: 7343-50. PMID 21894311 DOI: 10.1039/C1Ob05773A  0.674
2011 Bhabak KP, Vernekar AA, Jakka SR, Roy G, Mugesh G. Mechanistic investigations on the efficient catalytic decomposition of peroxynitrite by ebselen analogues. Organic & Biomolecular Chemistry. 9: 5193-200. PMID 21629895 DOI: 10.1039/C0Ob01234C  0.766
2011 Bhabak KP, Bhuyan BJ, Mugesh G. Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes. Dalton Transactions (Cambridge, England : 2003). 40: 2099-111. PMID 21321730 DOI: 10.1039/C0Dt01057J  0.646
2011 Roy G, Bhabak KP, Mugesh G. Interactions of Antithyroid Drugs and Their Analogues with Halogens and their Biological Implications Crystal Growth & Design. 11: 2279-2286. DOI: 10.1021/Cg101688V  0.768
2011 BHABAK KP, MUGESH G. Gold(I)-selenolate complexes: Synthesis, characterization and ligand exchange reactions Journal of Chemical Sciences. 123: 783-789. DOI: 10.1007/S12039-011-0166-4  0.633
2010 Bhabak KP, Mugesh G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Accounts of Chemical Research. 43: 1408-19. PMID 20690615 DOI: 10.1021/Ar100059G  0.702
2010 Bhabak KP, Mugesh G. Antithyroid drugs and their analogues protect against peroxynitrite-mediated protein tyrosine nitration--a mechanistic study. Chemistry (Weinheim An Der Bergstrasse, Germany). 16: 1175-85. PMID 20029917 DOI: 10.1002/Chem.200902145  0.679
2010 Bhabak KP, Mugesh G. Inhibition of peroxidase-catalyzed protein tyrosine nitration by antithyroid drugs and their analogues Inorganica Chimica Acta. 363: 2812-2818. DOI: 10.1016/J.Ica.2010.03.048  0.685
2010 Bhabak K, Mugesh G. Cover Picture: Antithyroid Drugs and their Analogues Protect Against Peroxynitrite-Mediated Protein Tyrosine Nitration-A Mechanistic Study (Chem. Eur. J. 4/2010) Chemistry - a European Journal. 16: 1087-1087. DOI: 10.1002/Chem.201090007  0.606
2009 Bhabak KP, Mugesh G. Synthesis and structure-activity correlation studies of secondary- and tertiary-amine-based glutathione peroxidase mimics. Chemistry (Weinheim An Der Bergstrasse, Germany). 15: 9846-54. PMID 19551790 DOI: 10.1002/Chem.200900818  0.697
2009 Bhabak KP, Mugesh G. Amide-based glutathione peroxidase mimics: effect of secondary and tertiary amide substituents on antioxidant activity. Chemistry, An Asian Journal. 4: 974-83. PMID 19378298 DOI: 10.1002/Asia.200800483  0.682
2009 Bhabak KP, Mugesh G. A synthetic model for the inhibition of glutathione peroxidase by antiarthritic gold compounds. Inorganic Chemistry. 48: 2449-55. PMID 19267501 DOI: 10.1021/Ic8019183  0.646
2008 Bhabak KP, Mugesh G. A simple and efficient strategy to enhance the antioxidant activities of amino-substituted glutathione peroxidase mimics. Chemistry (Weinheim An Der Bergstrasse, Germany). 14: 8640-51. PMID 18668498 DOI: 10.1002/Chem.200800963  0.678
2007 Bhabak KP, Mugesh G. Synthesis, characterization, and antioxidant activity of some ebselen analogues. Chemistry (Weinheim An Der Bergstrasse, Germany). 13: 4594-601. PMID 17299817 DOI: 10.1002/Chem.200601584  0.689
Show low-probability matches.